Search - tctmd.com

Displaying 101 - 120 of 641

Sort: Relevancy | Date

Presentation TCT 2015

Assessing Whether Superiority Exists: Design, Rationale, and Status of ABSORB IV

Presenter: Stephen G. Ellis, Patrick W. Serruys, Gregg W. Stone

October 14, 2015

Presentation TCT 2015

Featured Lecture: One-Year Patient-Level Pooled Meta-analysis From 4 ABSORB Trials in 3389 Randomized Patients

Presenter: Stephen G. Ellis, Patrick W. Serruys, Gregg W. Stone

October 14, 2015

Presentation TCT 2015

Identifying and Studying Data Gaps: Cangrelor Use What's Settled, and What's Not?

Presenter: Deepak L. Bhatt, Martin Rose, Gregg W. Stone

October 14, 2015

Presentation TCT 2015

When and How to Treat a Claudicant With an Occluded SFA

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore

October 14, 2015

News Conference News TCT 2015

Shelley Wood to Join CRF as Editorial Director

October 14, 2015

News Conference News TCT 2015

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

Presentation TCT 2015

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Gregg W. Stone

October 13, 2015

Presentation TCT 2015

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

Presenter: Gregg W. Stone, Bram D. Zuckerman, Jeffrey Shuren

October 13, 2015

Presentation TCT 2015

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 13, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

Presentation TCT 2015

VALcare: Device Description, Experiences, and Future Directions

Presenter: David H. Adams, Gregg W. Stone, David Meerkin

October 12, 2015

Presentation TCT 2015

MValve Docking System: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Maurice Buchbinder

October 12, 2015

Presentation TCT 2015

Valtech Cardiovalve: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Francesco Maisano

October 12, 2015

Presentation TCT 2015

A Novel Transcatheter Mitral Valved Stent for Secondary MR

Presenter: David H. Adams, Gregg W. Stone, Jose Luis Navia

October 12, 2015

Presentation TCT 2015

SinoMed AccuFit: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Patrick W. Serruys

October 12, 2015

Presentation TCT 2015

Tiara: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Anson Cheung

October 12, 2015

Presentation TCT 2015

Fortis: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Vinod H. Thourani

October 12, 2015

Presentation TCT 2015

Tendyne: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Neil E. Moat

October 12, 2015

Advertisement

Assessing Whether Superiority Exists: Design, Rationale, and Status of ABSORB IV

Featured Lecture: One-Year Patient-Level Pooled Meta-analysis From 4 ABSORB Trials in 3389 Randomized Patients

Identifying and Studying Data Gaps: Cangrelor Use What's Settled, and What's Not?

When and How to Treat a Claudicant With an Occluded SFA

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Shelley Wood to Join CRF as Editorial Director

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

VALcare: Device Description, Experiences, and Future Directions

MValve Docking System: Novel Design Features and Clinical Updates

Valtech Cardiovalve: Novel Design Features and Clinical Updates

A Novel Transcatheter Mitral Valved Stent for Secondary MR

SinoMed AccuFit: Novel Design Features and Clinical Updates

Tiara: Novel Design Features and Clinical Updates

Fortis: Novel Design Features and Clinical Updates

Tendyne: Novel Design Features and Clinical Updates

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content